Denali Therapeutics stock falls after Parkinson’s drug fails trial

Denali Therapeutics stock falls after Parkinson’s drug fails trial

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.